CSF2 and neoplasm: Although van den Engel et al. and others could show an enhanced anti-tumor immune response using a whole cell vaccine combined with GM-CSF exposure following lymphodepletion [5,6,7], generating tumor-directed T cells does not necessarily translate into an effective trafficking to the tumor site and tumor cell-killing [12].